ImmunoScape vs Umlaut.bio
ImmunoScape vs Umlaut.bio, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: ImmunoScape is on 58/100 and Umlaut.bio on 35/100.
Where each one leads
ImmunoScape
- our overall score: 58/100 against 35/100
- domain rating: 28/100 against 7/100
- funding raised: $49.7M against $3.0M
Umlaut.bio
Leads on none of the measures we hold for both companies.
At a glance
| Measure | ImmunoScape | Umlaut.bio |
|---|---|---|
| What it is | Developing novel immunotherapies and diagnostics for cancer. | Developing novel immunotherapies for cancer. |
| Category | Biotechnology, Cancer, Immunotherapy, Diagnostics | Biotechnology, Cancer, Immunotherapy, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2017 | 2022 |
| Headquarters | Singapore, Singapore | Cambridge, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | ImmunoScape | Umlaut.bio |
|---|---|---|
| Total funding | $49.7M | $3.0M |
| Latest round | Series B2 | Pre-Seed |
| Valuation | $1.1B | Not published |
| LinkedIn followers | 4,364 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | ImmunoScape | Umlaut.bio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 58/100 | 35/100 |
| Traction | 38/100 | 32/100 |
| Team | 70/100 | Not published |
| Search visibility | 23/100 | 8/100 |
| Quality | 68/100 | 48/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | F (37/100) |
| Domain ratingLink authority, 0-100 | 28/100 | 7/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | ImmunoScape | Umlaut.bio |
|---|---|---|
| Hosting | Not detected | Self Managed |
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Not detected |
| Analytics | Google Tag Manager | Not detected |
What users say
| Measure | ImmunoScape | Umlaut.bio |
|---|---|---|
| Reddit sentimentThreads we track | 6 positive, 0 negative across 6 threads | Not published |
“Singapore-based ImmunoScape Pioneers Next-Generation Cell Therapy for Solid Tumors; Announces Key Licensing Deal, New Board and SAB Appointments.”r/Quantisnow
ImmunoScape vs Umlaut.bio: common questions
Which is better, ImmunoScape or Umlaut.bio?
On our 0-100 score ImmunoScape rates higher (58/100 against 35/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do ImmunoScape and Umlaut.bio compare on the numbers?
ImmunoScape leads on our overall score (58/100 against 35/100), domain rating (28/100 against 7/100), funding raised ($49.7M against $3.0M).
What do real users say about ImmunoScape and Umlaut.bio?
ImmunoScape: 6 positive and 0 negative mentions across 6 Reddit threads we track, mostly in r/Quantisnow.
Read the full ImmunoScape review and pricing or the Umlaut.bio review and pricing. You can also browse other ImmunoScape alternatives we track.